Search results for abx831295

Fletikumab, Abbexa, abx831295

Fletikumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL20, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Fletikumab is under investigation in clinical trial NCT01038674 (Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis).